Contact
 
News about the Enterprise

Scientific Highlights of AIDS Vaccine 2013, Barcelona - February 21, 2014

AIDS Vaccine 2013 was hosted by the Global HIV Vaccine Enterprise together with the Catalan Program for HIV Vaccine Research (HIVACAT) at the Barcelona International Convention Center from 7 – 10 October.  More than 900 researchers, funders, advocates and policymakers met in Barcelona for the 13th AIDS Vaccine conference at a time of significant progress and challenges in HIV prevention research.  

Symposium on Nonhuman Primate Models for AIDS, November 2013 - February 21, 2014

Highlights from the 31st Annual Symposium on Nonhuman Primate Models for AIDS held on 3–6 November 2013, in Atlanta, Georgia (www.yerkes.emory.edu/aidsconf/). The symposium was divided into six sessions with 54 oral presentations and 83 poster presentations. Louis Picker was the keynote speaker and Beatrice Hahn made a special presentation. Here we report on five presentations organized around two themes.

Enterprise Calls for Timely Topics Proposals -- Help Identify Topics Critical to Advancing HIV Vaccine R&D - February 12, 2014

349
Timely Topics in HIV Vaccines is a science strategy program of the Global HIV Vaccine Enterprise, convening experts to respond to emerging priority issues in the field. Through an open call for proposals, the Enterprise aims to identify the most important strategic topics that need to be discussed and explored in a collaborative fashion.

Enterprise Webinar on Antibody Durability - December 3, 2013

The Enterprise held a webinar to share highlights from the recent thinktank on antibody durability, http://www.vaccineenterprise.org/timely-topics/antibody-durability/index.htm.

 

Enterprise Webinar on Strategic Directions for Therapeutic Vaccines Research - November 14, 2013

The Enterprise together with AVAC, the Bill & Melinda Gates Foundation and the Treatment Action Group (TAG) hosted a consultation in September on strategic directions for therapeutic vaccines research.  Join us on Monday, 18 November at 12:00 EST for a webinar to share highlights from the consultation. You can register for the webinar here, https://cc.readytalk.com/cc/s/registrations/new?cid=68wm0ch6bj72.

Join the Enterprise and Partners for a Webinar on a New Tool to Help Optimize HIV Vaccine Research - October 29, 2013

The Enterprise held a webinar on the challenges facing researchers who want to advance their vaccine candidate from preclinical studies to a first-in-human trial. The webinar introduced a new interactive webtool designed to help researchers navigate the landscape of expertise necessary for such transition and to provide estimated timelines and costs. Click here to view the webinar.

AIDS Vaccine 2013 Webcasts and Resources - October 16, 2013

AIDS Vaccine 2013 welcomed more than 900 of the world's leading vaccine researchers, funders and policy makers to Barcelona, Spain for four days of exchange, debate and direction-setting for the field. Check out the conference webcasts, http://www.aidsvaxwebcasts.org/ and ePosters, http://epostersonline.com/aidsvax2013.

Experts to Report On Advances in The Search For The Ultimate HIV Prevention Tool – A Vaccine – At AIDS Vaccine 2013 - September 25, 2013

More than 450 research studies outlining the latest advances and obstacles in the search for an AIDS vaccine will be presented and debated at AIDS Vaccine 2013, the world's only scientific meeting dedicated exclusively to HIV vaccine research.

Functional Glycomics in HIV Vaccine Design: Funding Opportunity and Workshop Report - August 1, 2013

The NIH is offering R01 grants to help investigate structural and conformational features of HIV glycosylation that may lead to novel HIV vaccine design approaches; and to elucidate the impact of differential glycosylation on the quality of the immune response to HIV.  The deadline to apply is 02 December, http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-056.html.

Latebreaker Abstracts - July 29, 2013

The deadline to submit later breaker abstracts for AIDS Vaccine 2013 is 11 August.  To submit yours, visit http://precis.preciscentral.com/User/UserLogin.asp?Action=New&EventID=48ab2f9b

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account